Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics

Journal of Medicinal Chemistry

Volumn 46, Issue 13, 2003, Pages 2755-2764

  Balzarini, Jan ^a   Pannecouque, Christophe ^a   De Clercq, Erik ^a   Pavlov, Andrey Y ^b   Printsevskaya, Svetlana S ^b   Miroshnikova, Olga V ^b   Reznikova, Marina I ^b   Preobrazhenskaya, Maria N ^b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b GAUSE INSTITUTE OF NEW ANTIBIOTICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROEREMOMYCIN; CHLOROPEPTIN I; COMPLESTATIN; DA 40926; DEXTRAN SULFATE; DMDA 40926; EREMOMYCIN; GLYCOPEPTIDE; PROTEINASE INHIBITOR; RISTOCETIN A DERIVATIVE; RITONAVIR; TEICOPLANIN DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; DRUG MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LYMPHOCYTE; MOLONEY MURINE SARCOMA ONCOVIRUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; FIBROBLASTS; GLYCOPEPTIDES; HIV-1; HIV-2; HUMANS; MICE; MOLONEY MURINE SARCOMA VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0038454664     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0300882     Document Type: Article

References (39)

1. Nagarajan, R. Glycopeptide Antibiotics; Marcel Dekker: New York, 1994.
2. Walsh, C. T. Vancomycin resistance: decoding the molecular logic. Science 1993, 261, 308-309.
3. Malabarba, A.; Nicas, T. I.; Thompson, R. S. Structural Modifications of Glycopeptide Antibiotics. Med. Res. Rev. 1997, 17, 69-137.
4. Pavlov, A. Y.; Preobrazhenskaya, M. N. Chemical Modification of Glycopeptide Antibiotics. Russ. J. Bioorg. Chem. 1998, 24, 570-587.
5. Cooper, R. D. G.; Snyder, N. J.; Zweifel, M. J.; Staszak, M. A.; Rodrigues, M. J.; Huff, B. E.; Thompson, R. C. Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity. J. Antibiot. 1996, 49, 575-581.
6. Ge, M.; Chen, Zh.; Onishi, H. R.; Kohler, J.; Silver, L. L.; Kerns, R.; Fukuzawa, S.; Thompson, C.; Kahne, D. Vancomycin Derivatives That Inhibit Peptidoglycan Synthesis without Binding D-Ala-D-Ala. Science 1999, 284, 507-511.
7. Goldman, R. C.; Baizman, E. R.; Longley, C. B.; Branstrom, A. A. Chlorobiphenyl-Desleucyl-Vancomycin Inhibits the Transglycosylase Required for Peptidoglycan Synthesis in Bacteria. FEMS Microbiol. Lett. 2000, 183, 209-214.
8. Printsevskaya, S. S.; Pavlov, A. Y.; Olsufyeva, E. N.; Mirchink, E. P.; Isakova, E. B.; Reznikova, M. I.; Goldman, R. C.; Branstrom, A. A.; Baizman, E. R.; Longley, C. B.; Sztaricskai, F.; Batta, G.; Preobrazhenskaya, M. N. Synthesis and Mode of Action of Hydrophobic Derivatives of the Glycopeptide Antibiotic Eremomycin and Des-(N-methyl-D-deucyl)eremomycin against Glycopeptide-Sensitive and -Resistant Bacteria. J. Med. Chem. 2002, 45, 1340-1347.
9. Roy, R. S.; Yang, P.; Kodali, S.; Xiong, Y.; Kim, R. M.; Griffin, P. R.; Onishi, R,; Kohler, J.; Silver, L. L.; Chapman, K. Direct Interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis. Chem. Biol. 2001, 8, 1095-1106.
10. Eggert, U. S.; Ruiz, N.; Falcone, B. V.; Branstrom, A. A.; Goldman, R. C.; Silhavy, T. J.; Kahne, D. Genetic Basis for Activity Differences between Vancomycin and Glycolipid Derivatives of Vancomycin. Science 2001, 294, 361-364.
11. Printsevskaya, S. S.; Pavlov, A. Y.; Olsufyeva, E. N.; Mirchink, E. P.; Preobrazhenskaya, M. N. The Role of the Glycopeptide Framework in the Antibacterial Activity of Hydrophobic Derivatives of Glycopeptide Antibiotics. J. Med. Chem. 2003, 46, 1204-1209.
12. Matsuzaki, K.; Ikeda, H.; Ogino, T.; Matsumoto, A.; Woodruff, H. B.; Tanaka, H.; Omura, S. Chloropeptins I and II. Novel inhibitors against gp-120-CD4 binding from Streptomyces sp. J. Antibiot. 1994, 47, 1173-1174.
13. Naruse, N.; Oka, M.; Konishi, M.; Oki, T. New antiviral antibiotics, kistamycins A and B. II. Structural determination. J. Antibiot. 1993, 46, 1812-1818.
14. Nicolau, K. C.; Boddy, C. N. C.; Brase, S.; Winssinger, N. Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics. Angew. Chem., Int. Ed. 1999, 38, 2096-2152.
15. Nagarajan, R.; Schabel, A. A.; Occolowitz, J. L.; Counter, F. T.; Ott, J. L.; Felty-Duckworth, A. M. Syntesis and Antimicrobial Activity of N-alkyl Vancomycins. J. Antibiot. 1989, 42, 63-72.
16. Nagarajan, R. Structure-activity relationships of vancomycintype glycopeptides antibiotics. J. Antibiot. 1993, 46, 1181-1195.
17. Pavlov, A. Y.; Berdnikova, T. F.; Olsufyeva, E. N.; Miroshnikova, O. V.; Filiposyanz, S. T.; Preobrazhenskaya, M. N.; Scottani, C.; Colombo, L.; Goldstein, B. P. Carboxamides and Hydrazide of Glycopeptide Antibiotic Eremomycin. Synthesis and Antibacterial Activity. J. Antibiot. 1996, 49, 194-198.
18. Pavlov, A. Y.; Lazhko, E. I.; Preobrazhenskaya, M. N. A New Type of Chemical Modification of Glycopeptides Antibiotics; Aminomethylated Derivatives of Eremomycin and Their Antibacterial Activity. J. Antibiot. 1997, 50, 509-513.
19. Miroshnikova, O. V.; Printsevskaya, S. S.; Olsufyeva, E. N.; Pavlov, A. Y.; Nilius, A.; Hensey-Rudloff, D.; Preobrazhenskaya, M. N. Structure-Activity Relationships in the Series of Eremomycin Carboxamides. J. Antibiot. 2000, 53, 286-293.
20. Gerhard, U.; Mackay, J. P.; Maplestone, R. A.; Williams, D. H. The Role of the Sugar and Chlorine Substituents in the Dimerization of Vancomycin Antibiotics. J. Am. Chem. Soc. 1993, 115, 232-237.
21. 63-Carboxamides of Teicoplanin Antibiotics. Structure-Activity Relationships. J. Med. Chem. 1989, 32, 2450-2460.
22. Hermann, R.; Ripamonti, F.; Romano, G.; Restelli, E.; Ferrari, P.; Goldstein, B. P.; Berti, M.; Ciabatti, R. Synthesis and Antibacterial Activity of Derivatives of the Glycopeptide Antibiotic A-40926 and Its Aglycone. J. Antibiot. 1996, 49, 1236-1247.
23. Preobrazhenskaya, M. N.; Pavlov, A. Y.; Maffioli, S. I.; Romano, H.; Ciabatti, R. The Synthesis and Antibacterial Activity of Di-Alkylated Derivatives of the Glycopeptide Antibiotic A-40926 and Their Amides. 42nd ICAAC Abstracts, San Diego, CA September 27-30, 2002; ICAAC: Washington, DC, 2002; p F-358.
24. Maffiolli, S. I.; Romano, G.; Marzorati, E.; Pavlov, A. Y.; Preobrazhenskaya, M. N.; Ciabatti, R. The Synthesis and Antibacterial Activity of Monoalkylated Derivatives of the Glycopeptide Antibiotic A40926 and Their Amides. 42nd ICAAC Abstracts, San Diego, CA, September 27-30, 2002; ICAAC: Washington, DC, 2002; p F-357.
25. Kannan, R.; Harris, C. M.; Harris, T. M.; Waltho, J. P.; Skeiton, N. J.; Williams, D. H. Function of the amino sugar and N-terminal acid of the antibiotic vancomycin in its complexation with cell wall peptides. J. Am. Chem. Soc. 1988, 110, 2946- 2953.
26. Berdnikova, T. F.; Lomakina, N. N.; Olsufyeva, E. N.; Alexandrova, L. G.; Potapova, N. P.; Rozinov, B. V.; Malkova, I. V.; Orlova, G. I. Structure and Antimicrobial Activity of Products of Partial Degradation of Antibiotic Eremomycin. Antibiot. Chemother. (Moscow) 1991, 36, 28-31.
27. Miroshnikova, O. V.; Berdnikova, T. F.; Olsufyeva, E. N.; Pavlov, A. Y.; Reznikova, M. I.; Preobrazhenskaya, M. N.; Ciabatti, R.; Malabarba, A.; Colombo, L. A Modification of the N-Terminal Amino Acid in the Eremomycin Aglycone. J. Antibiot. 1996, 49, 1157-1161.
28. Bognar, R.; Sztaricskai, F.; Munk, M. E.; Tamas, J. Structure and Stereochemistry of Ristosamine. J. Org. Chem. 1974, 39, 2971-2974.
29. Malabarba, A.; Ferrari, P.; Gallo, G. G.; Kettenring, J.; Cavalleri, B. Teicoplanin, Antibiotics from Actinoplanes teichomyceticus nov. sp. VII. Preparation and NMR Characteristics of the Aglycone of Teicoplanin. J. Antibiot. 1986, 39, 1430-1442.
30. Pavlov, A. Y.; Preobrazhenskaya, M. N.; Malabarba, A.; Ciabatti, R.; Colombo, L. Mono and Double Modified Teicoplanin Aglycon Derivatives on the Amino Acid No. 7; Structure-Activity Relationship. J. Antibiot. 1998, 51, 73-81.
31. Malabarba, A.; Trani, A.; Ferrari, P.; Pallanza, R.; Cavalleri, B. Synthesis and Biological Activity of Some Esters of the N-Acetylglucosaminyl Aglycone and of the Aglycone of Teicoplanin. J. Antibiot. 1987, 40, 1572-1587.
32. Malabarba, A.; Ciabatti, R.; Kettenring, J.; Scotti, R.; Candiani, G.; Pallanza, R.; Berti, M.; Goldstein, B. P. Synthesis and Antibacterial Activity of a Series of Basic Amides of Teicoplanin and Deglucoteicoplanin with Polyamines. J. Med. Chem. 1992, 35, 4054-4060.
33. Trani, A.; Ferrari, P.; Pallanza, R.; Ciabatti, R. Thiooureas and Isothiouronium Salts of the Aglycone of Teicoplanin. 1. Synthesis and Biological Activity. J. Antibiot. 1989, 42, 1268-1282.
34. Malabarba, A.; Ciabatti, R.; Maggini, M.; Ferrari, P.; Vekey, K.; Colombo, L.; Denaro, M. Structural Modifications of the Active Site in Teicoplanin and Related Glycopeptides. 2. Deglucoteicoplanin-Derived Tetrapeptide. J. Org. Chem. 1996, 61, 2151-2157.
35. Cavalleri, B.; Ferrari, P.; Malabarba, A.; Magni, A.; Pallanza, R.; Gallo, G. G. Teicoplanin, Antibiotics from Actinoplanes teichomyceticus nov. sp. VIII. Opening of the Polypeptide Chain of Teicoplanin Aglycone under Hydrolytic Conditions. J. Antibiot. 1987, 40, 49-59.
36. Balzarini, J.; Naesens, L.; Slachmuylders, J.; Niphuis, H.; Rosenberg, I.; Holý, A.; Schellekens, H.; De Clercq, E. 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys. AIDS 1991, 5, 21-28.
37. De Clercq, E.; Merigan, T. C. Moloney sarcoma virus-induced tumors in mice: inhibition of stimulation by (poly rI):(poly rC). Proc. Soc. Exp. Biol. Med. 1971, 137, 590-594.
38. Popovic, M.; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224, 497-500.
39. Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kukla, M. J.; Breslin, H. J.; Raeymaeckers, A.; Van Gelder, J.; Woestenborghs, R.; Heykants, J. Potent and selective inhibition of HIV-1 replication by a novel series of TIBO derivatives. Nature 1990, 343, 470-474.